Key result
Two-bed polyvascular disease is linked to ~65% higher CV mortality vs single-bed disease in CKD.
Why the study?
Does the presence of polyvascular disease increase cardiovascular mortality in vascular surgery patients with chronic kidney disease?
Cohort (n=2,933)
Does the presence of polyvascular disease increase cardiovascular mortality in vascular surgery patients with chronic kidney disease?
Hazard Ratio: 1.65 (95% CI 1.09–2.48)
Polyvascular disease is highly prevalent in vascular surgery patients with CKD and is independently associated with increased long-term cardiovascular mortality.
BACKGROUND: Atherosclerotic disease is often extended to multiple affected vascular beds (AVB). Polyvascular disease (PVD) and chronic kidney disease (CKD) have both separately been associated with an adverse cardiovascular outcome. We assessed the prevalence of PVD in vascular surgery patients with preoperative CKD and studied the influence on long-term cardiovascular survival. METHODS: Consecutive patients (2933) were preoperatively screened for PVD, defined as 1-, 2- or 3-AVB. Preoperative glomerular filtration rate (GFR in ml/min/1.73 m(2) body-surface area) was estimated by the Modification of Diet in Renal Disease (MDRD) prediction equation, and patients were categorized according their estimated GFR. Primary end point was (cardiovascular) mortality during a median follow-up of 6.0 years (IQR 2-9). RESULTS: Preoperative MDRD-GFR was classified as normal kidney function (GFR >or= 90) or mild (GFR 60-89), moderate (GFR 30-59) and severe (GFR < 30) kidney disease in 779 (27%), 1423 (48%), 605 (21%) and 124 (4%) patients, respectively. One-vessel disease was present in 54% of the patients with normal kidney function, while 62% of the patients with CKD (GFR < 60) had PVD. In patients with moderate or severe kidney disease, the presence of PVD was independently associated with even higher cardiovascular mortality rates (2-AVB: HR 1.65 95%CI 1.09-2.48; 3-AVB: 2.07 95%CI 1.08-3.99), compared to 1-AVB. CONCLUSION: Patients with CKD had a high prevalence of PVD, which was independently associated with increased all-cause and cardiovascular mortality.
No takes yet. Share an insight, caveat, or question.
Kuijk et al. (2010) conducted a cohort in Chronic kidney disease and polyvascular atherosclerotic disease (n=2,933). Polyvascular disease (2-AVB or 3-AVB) vs. 1-vessel disease (1-AVB) was evaluated on (cardiovascular) mortality (HR 1.65, 95% CI 1.09-2.48). In vascular surgery patients with moderate/severe CKD, 2-bed and 3-bed polyvascular disease were associated with increased cardiovascular mortality compared to 1-bed disease (HR 1.65 and HR 2.07).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: